Page last updated: 2024-10-25

desipramine and Diabetic Glomerulosclerosis

desipramine has been researched along with Diabetic Glomerulosclerosis in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research Excerpts

ExcerptRelevanceReference
"Diabetic nephropathy is a common complication of diabetes, but there are currently few treatment options."1.48Alpha-mangostin attenuates diabetic nephropathy in association with suppression of acid sphingomyelianse and endoplasmic reticulum stress. ( Duan, W; Gao, L; Lei, M; Liao, Z; Liu, L; Liu, T; Nizigiyimana, P; Xu, B, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, T1
Duan, W1
Nizigiyimana, P1
Gao, L1
Liao, Z1
Xu, B1
Liu, L1
Lei, M1

Other Studies

1 other study available for desipramine and Diabetic Glomerulosclerosis

ArticleYear
Alpha-mangostin attenuates diabetic nephropathy in association with suppression of acid sphingomyelianse and endoplasmic reticulum stress.
    Biochemical and biophysical research communications, 2018, 02-05, Volume: 496, Issue:2

    Topics: Activating Transcription Factor 4; Albuminuria; Animals; Apoptosis; Blood Glucose; Caspase 12; Desip

2018